Representative Julie Johnson (D-Texas) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on August 14th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.
Representative Julie Johnson also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Fidelity National Information Services (NYSE:FIS) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of ConocoPhillips (NYSE:COP) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 8/14/2025.
- Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 8/14/2025.
UnitedHealth Group Price Performance
NYSE UNH opened at $334.74 on Friday. The company’s 50 day moving average is $295.01 and its two-hundred day moving average is $366.14. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $303.16 billion, a price-to-earnings ratio of 14.50, a PEG ratio of 2.23 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.
Institutional Investors Weigh In On UnitedHealth Group
Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 3.3% in the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock valued at $6,624,411,000 after purchasing an additional 675,075 shares during the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $3,837,207,000. Finally, Dodge & Cox raised its holdings in shares of UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after buying an additional 4,730,192 shares during the period. 87.86% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research firms recently issued reports on UNH. Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Morgan Stanley increased their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Finally, Robert W. Baird reiterated an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.
Check Out Our Latest Research Report on UnitedHealth Group
About Representative Johnson
Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.
Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Bank Stocks – Best Bank Stocks to Invest In
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Short Selling – The Pros and Cons
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.